openPR Logo
Press release

Diabetes Drugs Market | Growth Opportunities | Challenges | Industry Analysis | Technological Trend | Demand Forecast by 2025

08-07-2018 07:47 AM CET | Health & Medicine

Press release from: Reports Monitor

Diabetes Drugs Market

Diabetes Drugs Market

Diabetes drugs lower the glucose levels in the blood. There are different classes of anti-diabetic drugs; the drugs are prescribed by the doctor considering various factors, for instance, the nature of diabetes, age, and situation of the person. Except for insulin, exenatide, liraglutide, and pramlintide, remaining others are orally administered. The main cause of diabetes mellitus type 1 is due to lack of insulin. Insulin is injected with Type I diabetes.

Due to insulin resistance by cells, diabetes mellitus type 2 is caused. Type 2 diabetes mellitus is the most common type of diabetes. Diabetes mellitus type 2 is treated by administering agents which increase the amount of insulin secreted by the pancreas. Patients with type 1 or type 2 diabetes have a range of symptoms, some of them are frequent urination, usually at night, excessive thirst, extreme hunger, dry skin, weakness, recurring or slow-healing infections, weight loss, blurred vision, tingling in the hands or feet, nausea, yeast infections, urinary tract infections, skin Infections, and skin disorders.

Type 2 diabetes often begins to develop well before the disease is diagnosed.

Download PDF Sample with Popular Trends @

Microvascular and macrovascular complications, for instance, retinopathy (eye disease), nephropathy (kidney disease), neuropathy (nervous system disease), and large vessel disease are caused due to poor blood sugar control. As a result of which, weight excess, high blood pressure, smoking, and high cholesterol levels get worse.

Factors Influencing Market Scenario:
According to International Diabetes Federation (IDF) as of 2015, an estimated 415 million people had diabetes globally, with 90% of the cases of type 2 diabetes, which represents 8.3% of the adult population. In 2014, the economic cost of diabetes globally was estimated to be US$ 612 billion. In 2012, in the United States, the cost of diabetes was $245 billion.

According to WHO, rising incidences of diabetes is one of the important drivers for diabetes drugs market. A sedentary lifestyle will propel the growth of the market. In addition, research & development initiatives, technological advancements, and improved healthcare facilities are the key factors fueling the growth of the market. Changing lifestyle and the adoption of fast food that has resulted in the high prevalence of obesity is expected to fuel the industry demand. However, stringent regulatory environment and time-consuming approval process are the major restraining factors that are hampering the growth of the diabetes drugs market. Due to the high cost, a large population cannot afford the treatment and is depending on generic drugs, ultimately affecting the growth of the overall market.

Regional analysis:
Depending upon the geographical analysis, the market includes major four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA). Asia Pacific region is expected to be one of the fastest growing markets due to the adoption of fast food and unhealthy food habits. North America is also expected to dominate the market, owing to the changing lifestyle that has resulted in obesity and increasing incidents of diabetes.

Key Players:
The global diabetes drugs market comprises some of the key players such as Abbott Laboratories, Bayer AG, Boehringer Ingelheim GmbH, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Novartis AG, Novo Nordisk A/S, Sanofi, and Takeda Pharmaceutical Company Limited.

Know More | Full Report Link @

Recent Developments:
• In May 2018, a review of 13 research studies was analyzed. The data suggest that the drug ‘semaglutide’ helped people suffering from type 2 diabetes to have a better control over blood glucose as compared to a number of medications. Panagiotis Andreadis, MD, who is heading the research study, stated that the medication also helps patients lose their weight. Dr. Andreadis further stated, for the patients whose priority is weight loss, Semaglutide could be used as an add-on in patients inadequately controlled with oral agents, with or without insulin. In December 2017, Novo Nordisk A/S's Ozempic (semaglutide) received approval from the U.S. FDA and was launched in February. This research study was published in the month of May in the journal Diabetes, Obesity, and Metabolism.

• In May 2018, Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced that the company's patent for its invention for Oral Administrations of Proteins has been allowed by the United States Patent and Trademark Office. The CEO of Oramed, Nadav Kidron, stated that this patent gives protection to the company’s proprietary POD™ Technology, paving the entrance into the U.S. market, which is one of the largest markets globally.

• In May 2018, Dr. Fernanda De Felice and her research team at Queen's University have discovered a disease mechanism common to Alzheimer's disease and Type 2 Diabetes. The molecular links between Alzheimer's disease and diabetes suggest novel therapeutic strategies based on anti-diabetic agents. Dr. De Felice further added that to treat this devastating disease and preserve brain health, understanding of the pathway involved in the development of the complex symptoms of Alzheimer's disease will be the key to identifying more therapeutic targets.

Diabetes Drugs Market Segmentation
By Drug Type:
• Injectable Drugs
o Exenatide
o Insulin
o Liragultide
o Pramlintide

• Oral Drugs
o Alpha-glucosidase Inhibitors
o Biguanides
o Bile Acid Sequestrants
o DPP-4 Inhibitors
o Meglitinides and D-Phenylalanine Derivatives
o Sulfonylureas
o Others

By Application:
• Type 1 Diabetes
• Type 2 Diabetes

Regions Covered:
o North America
o Europe
Rest of Europe
o Asia-Pacific
South Korea
Rest of Asia-Pacific
Saudi Arabia
South Africa
Rest of LAMEA

About Us:
Reports Monitor is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries including Healthcare, Technology, Chemicals, Materials, and Energy. With an intrinsic understanding of many business environments, Reports Monitor provides strategic objective insights.

We periodically update our market research studies to ensure our clients get the most recent, relevant, and valuable information. Reports Monitor has a strong base of analysts and consultants from assorted areas of expertise. Our industry experience and ability to zero-in on the crux of any challenge gives you and your organization the ability to secure a competitive advantage.

Contact Us:
Mr. Jay Matthews
Direct: +1 513 549-5911 (U.S.)
+44 203 318 2846 (U.K.)

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Diabetes Drugs Market | Growth Opportunities | Challenges | Industry Analysis | Technological Trend | Demand Forecast by 2025 here

News-ID: 1165245 • Views: 154

More Releases from Reports Monitor

2019 Global Smart Home Security and Safety Systems Market Trend Analysis and Ind …
Smart Home Security and Safety Systems Market GMD analysis model indicates that the aggregated revenue of global smart home security & safety systems market during 2019-2025 is expected to reach $134.5 billion owing to growing adoption of various types of smart security devices in global households. Have Questions? Request a sample or make an Inquiry before buying this report by clicking the link below:- Scope of the Report: Highlighted with 72
Radar Sensor Market 2019 Top Key Players: NXP Semiconductors N.V., Robert Bosch …
Radar Sensor Market The report provides a global analysis of Radar Sensor Market data from 2019 to 2024. The report reveals the overview, chain structure, and illustrate the industry’s current situation, evaluate global market volume/share. The market report studies key player’s Profiles/Analysis, product insights, regional analysis insights, product types, and product application insights. The market has been qualified based on a comprehensive market analysis with inputs from industry experts. Have Questions?
OKR Software Market report with Leading players: SpiraLinks, Wrike, BetterWorks, …
2019-2025 OKR Software Market Report with Depth Analysis: The report provides a global analysis of the OKR Software Market report provides Insightful information to the clients enhancing their basic leadership capacity identified. This Report is segmented into Manufactures, Types, Applications, and Regions. The market covers the wide spectrum of the factors governing future growth, including drivers, challenges, emerging trends, technology changes, and environmental factors. The global OKR Software market size was xx million US$
Event Logistics Market analysis report with Major players Rhenus Logistics, UPS, …
Event Logistics Market Market Overview of Event Logistics Market: The report provides a global analysis of Event Logistics Market Report provides Insightful information to the clients enhancing their basic leadership capacity identified. This Report is segmented into Manufactures, Types, Applications, and Regions. The market covers the wide spectrum of the factors governing future growth including drivers, challenges, emerging trends, technology changes, and environmental factors. The global Event Logistics market size was xx

All 10163 Releases

More Releases for Diabetes

Global Diabetes Industry
Global Diabetes Industry Market Insight Global diabetes market is expected to grow at a CAGR of 7.9% percent for the forecasted period of 2016-2021. The market is segmented on the basis of type of diabetes, drugs class and diabetic devices. Diabetic drugs have the highest market share amongst drugs and devices and are also expected to have the highest growth rate with a CAGR of 9%. Some of the top selling
27th European Diabetes Congress
Rising awareness, new technologies and practical approaches within the field of diabetes and endocrine disorders in world’s leading diabetes Conferences One in eight ladies can develop a diabetes disorder throughout her lifespan. And, the amount of individuals affected by diabetes disorders continues to rise every year. However the larger drawback is that almost 60 minutes of those individuals are fully unaware of their condition as well as a way to heal
27th European Diabetes Congress
We would like to invite your team as a Speakers/Delegates. On behalf of Organizing Committee, we take this opportunity in extending a warm and cordial welcome to you to be part of “27th European Diabetes Congress”, held conjointly with multifarious scientific associations, eminent researchers and scholars from all around the globe during June 20-21, 2018 at Rome, Italy. It is an immense pleasure and privilege having you here with us
Diabetes Gastroparesis Market grows with rising prevalence of diabetes
Diabetes type 1 and type 2 are one of the most common chronic diseases prevalent in the world, affecting millions of people. One of the disorders associated with diabetes type 1 and type 2 is gastroparesis, which is characterized by the delayed emptying of the stomach. One of the major causes of gastroparesis is damage to the vagus nerve, reducing the mobility of the stomach contents. Diabetic neuropathy affects the
18th European Diabetes Congress
It takes us immense pleasure to announce the conference that 18th European Diabetes Congress which is going to be held during July 17-18, 2017 at Lisbon, Portugal. Euro Diabetes 2017 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Diabetes
Chef Gayle Gaggero is worried. Gaggero, CEO of Kids Culinary Adventures (KCA), has read the reports from the Centers for Disease Control indicating the dramatic rise of Type II Diabetes in children. This rise has been directly linked to the increase in childhood obesity. Gaggero asserts that childhood obesity rates are tantamount to a brewing epidemic. Children, and some parents for that matter, do not know how to